Fresenius Medical Care AG (FMS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.40 is considered Undervalued compared with the five-year average of 13.84. The fair price of Fresenius Medical Care AG (FMS) is between 28.96 to 43.51 according to relative valuation method. Compared to the current price of 23.47 USD , Fresenius Medical Care AG By Undervalued By 18.96%.

Relative Value

Fair Zone

28.96-43.51

Current Price：23.47

18.96%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Fresenius Medical Care AG (FMS) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Fresenius Medical Care AG (FMS) has a current Price-to-Book (P/B) ratio of 0.45. Compared to its 3-year average P/B ratio of 0.71, the current P/B ratio is approximately -36.52% higher. Relative to its 5-year average P/B ratio of 0.91, the current P/B ratio is about -50.84% higher. Fresenius Medical Care AG (FMS) has a Forward Free Cash Flow (FCF) yield of approximately 15.69%. Compared to its 3-year average FCF yield of 14.38%, the current FCF yield is approximately 9.12% lower. Relative to its 5-year average FCF yield of 13.45%, the current FCF yield is about 16.64% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for FMS competitors is 2.95, providing a benchmark for relative valuation. Fresenius Medical Care AG Corp (FMS.N) exhibits a P/S ratio of 0.57, which is -80.54% above the industry average. Given its robust revenue growth of 8.82%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of FMS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of FMS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is FMS currently overvalued or undervalued?

Fresenius Medical Care AG (FMS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.40 is considered Undervalued compared with the five-year average of 13.84. The fair price of Fresenius Medical Care AG (FMS) is between 28.96 to 43.51 according to relative valuation method. Compared to the current price of 23.47 USD, Fresenius Medical Care AG is Undervalued By 18.96%.

What is Fresenius Medical Care AG (FMS) fair value?

FMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Fresenius Medical Care AG (FMS) is between 28.96 to 43.51 according to relative valuation method.

How does FMS's valuation metrics compare to the industry average?

The average P/S ratio for FMS's competitors is 2.95, providing a benchmark for relative valuation. Fresenius Medical Care AG Corp (FMS) exhibits a P/S ratio of 0.57, which is -80.54% above the industry average. Given its robust revenue growth of 8.82%, this premium appears unsustainable.

What is the current P/B ratio for Fresenius Medical Care AG (FMS) as of Mar 03 2026?

As of Mar 03 2026, Fresenius Medical Care AG (FMS) has a P/B ratio of 0.45. This indicates that the market values FMS at 0.45 times its book value.

What is the current FCF Yield for Fresenius Medical Care AG (FMS) as of Mar 03 2026?

As of Mar 03 2026, Fresenius Medical Care AG (FMS) has a FCF Yield of 15.69%. This means that for every dollar of Fresenius Medical Care AG's market capitalization, the company generates 15.69 cents in free cash flow.

What is the current Forward P/E ratio for Fresenius Medical Care AG (FMS) as of Mar 03 2026?

As of Mar 03 2026, Fresenius Medical Care AG (FMS) has a Forward P/E ratio of 9.40. This means the market is willing to pay $9.40 for every dollar of Fresenius Medical Care AG's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Fresenius Medical Care AG (FMS) as of Mar 03 2026?

As of Mar 03 2026, Fresenius Medical Care AG (FMS) has a Forward P/S ratio of 0.57. This means the market is valuing FMS at $0.57 for every dollar of expected revenue over the next 12 months.

FMS Valuation